Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Palmvitee is a biotechnology and nutraceutical company focused on the development and commercialization of palm-based tocotrienols, a potent form of Vitamin E. The company specializes in extracting high-purity tocotrienol-rich fractions (TRF) from palm oil for use in therapeutic and health-supplement applications. Its primary research and product focus areas include cardiovascular health, neuroprotection, and cholesterol management. Palmvitee's products are designed to leverage the antioxidant and anti-inflammatory properties of tocotrienols to address chronic conditions such as hyperlipidemia and neurodegenerative risks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Palmvitee.